{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:12:35Z","timestamp":1788599555440,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bmc.2026.118778","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T14:13:28Z","timestamp":1786889608000},"page":"118778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel hydrazone-linked pyridin-1-ium salts as multi-targeted agents for Alzheimer's disease: design, synthesis, in vitro and in silico studies"],"prefix":"10.1016","volume":"142","author":[{"given":"Hoang","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Quoc","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Thi Thu","family":"Hien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Xuan","family":"Vinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu Minh","family":"Duc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Thi Thanh","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi","family":"Hien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Vu Thuy","family":"Linh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Quoc","family":"Thang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham Thi Ngoc","family":"Minh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiep K.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi-Huyen-Trang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc-Vinh","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong-Thao","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bmc.2026.118778_bb0005","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer's disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.bmc.2026.118778_bb0010","article-title":"Alzheimer's disease drug development pipeline: 2024","volume":"10","author":"Cummings","year":"2024","journal-title":"Alzheimer's Dementia: Transl Res Clin Interventions"},{"key":"10.1016\/j.bmc.2026.118778_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107152","article-title":"A comprehensive review of multi-target directed ligands in the treatment of Alzheimer\u2019s disease","volume":"144","author":"Pathak","year":"2024","journal-title":"Bioorg Chem"},{"issue":"1","key":"10.1016\/j.bmc.2026.118778_bb0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.14283\/jpad.2018.43","article-title":"Revisiting the cholinergic hypothesis in Alzheimer\u2019s disease: emerging evidence from translational and clinical research","volume":"6","author":"Hampel","year":"2019","journal-title":"J Prevention Alzheimer\u2019s Dis"},{"issue":"19","key":"10.1016\/j.bmc.2026.118778_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26199444","article-title":"Alzheimer\u2019s disease: from molecular mechanisms to promising therapeutic strategies","volume":"26","author":"Ivanova","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"1\u20133","key":"10.1016\/j.bmc.2026.118778_bb0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2010.01.042","article-title":"Acetylcholinesterase: from 3D structure to function","volume":"187","author":"Dvir","year":"2010","journal-title":"Chem Biol Interact"},{"issue":"4","key":"10.1016\/j.bmc.2026.118778_bb0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1515\/revneuro-2019-0089","article-title":"Amyloid-\u03b2, tau, and the cholinergic system in Alzheimer\u2019s disease: seeking direction in a tangle of clues","volume":"31","author":"Majdi","year":"2020","journal-title":"Rev Neurosci"},{"issue":"9","key":"10.1016\/j.bmc.2026.118778_bb0040","doi-asserted-by":"crossref","first-page":"6994","DOI":"10.1039\/D5RA00488H","article-title":"Discovery of novel theophylline derivatives bearing tetrazole scaffold for the treatment of Alzheimer\u2019s disease","volume":"15","author":"Hung","year":"2025","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2026.118778_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and alzheimer&apos;s disease","volume":"34","author":"Brien","year":"2011","journal-title":"Annu Rev Neurosci"},{"issue":"5","key":"10.1016\/j.bmc.2026.118778_bb0050","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer\u2019s disease: strategies for disease modification","volume":"9","author":"Citron","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2026.118778_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115522","article-title":"Alzheimer\u2019s disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs","volume":"211","author":"Monteiro","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.bmc.2026.118778_bb0060","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1021\/acschemneuro.8b00420","article-title":"Structure-based survey of the binding modes of BACE1 inhibitors","volume":"10","author":"Hu","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2026.118778_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111475","article-title":"BACE1 as an early biomarker and its relevance to risk factors for Alzheimer\u2019s disease","volume":"230","author":"Ohno","year":"2025","journal-title":"Brain Res Bull"},{"issue":"3","key":"10.1016\/j.bmc.2026.118778_bb0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40263-019-00613-7","article-title":"A close look at BACE1 inhibitors for Alzheimer\u2019s disease treatment","volume":"33","author":"Das","year":"2019","journal-title":"CNS Drugs"},{"issue":"21","key":"10.1016\/j.bmc.2026.118778_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113098","article-title":"Dual inhibitors of AChE and BACE-1 for reducing A\u03b2 in Alzheimer\u2019s disease: from in silico to in vivo","volume":"23","author":"Stern","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.bmc.2026.118778_bb0080","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1021\/acs.jmedchem.7b00393","article-title":"BACE-1 inhibitors: from recent single-target molecules to multitarget compounds for Alzheimer\u2019s disease: Miniperspective","volume":"61","author":"Prati","year":"2018","journal-title":"J Med Chem"},{"issue":"13","key":"10.1016\/j.bmc.2026.118778_bb0085","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/S0040-4020(01)87332-4","article-title":"Conformational behaviour and E\/Z isomerization of N-acyl and N-aroylhydrazones","volume":"42","author":"Palla","year":"1986","journal-title":"Tetrahedron"},{"issue":"1","key":"10.1016\/j.bmc.2026.118778_bb0090","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/14756366.2018.1555536","article-title":"(E)-N\u2019-Arylidene-2-(4-oxoquinazolin-4 (3H)-yl) acetohydrazides: synthesis and evaluation of antitumor cytotoxicity and caspase activation activity","volume":"34","author":"Huan","year":"2019","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2026.118778_bb0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2026.118778_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2026.130560","article-title":"Novel imidazolium salts bearing 2-oxindoles scaffold as potent acetylcholinesterase inhibitors for Alzheimer\u2019s disease: design, synthesis, in vitro and in silico studies","volume":"134","author":"Tien","year":"2026","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.bmc.2026.118778_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/ph19010005","article-title":"In silico investigation of amidine-based BACE-1 inhibitors against Alzheimer\u2019s disease: SAR, pharmacokinetics, molecular docking and dynamic simulations","volume":"19","author":"Gandhi","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"23","key":"10.1016\/j.bmc.2026.118778_bb0110","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1021\/acs.jmedchem.6b00307","article-title":"Discovery of the 3-imino-1, 2, 4-thiadiazinane 1, 1-dioxide derivative verubecestat (MK-8931)\u2013a \u03b2-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer\u2019s disease","volume":"59","author":"Scott","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118778_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.06.011","article-title":"A new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies","volume":"309","author":"Gerlits","year":"2019","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmc.2026.118778_bb0120","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejmech.2015.08.052","article-title":"New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer\u2019s disease","volume":"103","author":"Luo","year":"2015","journal-title":"Eur J Med Chem"},{"issue":"16","key":"10.1016\/j.bmc.2026.118778_bb0125","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"issue":"2","key":"10.1016\/j.bmc.2026.118778_bb0130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"3","key":"10.1016\/j.bmc.2026.118778_bb0135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jcc.26779","article-title":"Improving ligand-ranking of AutoDock Vina by changing the empirical parameters","volume":"43","author":"Pham","year":"2022","journal-title":"J Comput Chem"},{"issue":"16","key":"10.1016\/j.bmc.2026.118778_bb0140","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"issue":"39","key":"10.1016\/j.bmc.2026.118778_bb0145","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1021\/acs.jpcb.4c04901","article-title":"Introductory tutorials for simulating protein dynamics with GROMACS","volume":"128","author":"Lemkul","year":"2024","journal-title":"J Phys Chem B"},{"issue":"4","key":"10.1016\/j.bmc.2026.118778_bb0150","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J Comput Chem"},{"issue":"43","key":"10.1016\/j.bmc.2026.118778_bb0155","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"J Phys Chem A"},{"issue":"12","key":"10.1016\/j.bmc.2026.118778_bb0160","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J Appl Phys"},{"issue":"1","key":"10.1016\/j.bmc.2026.118778_bb0165","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J Chem Phys"},{"issue":"12","key":"10.1016\/j.bmc.2026.118778_bb0170","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J Chem Phys"},{"issue":"12","key":"10.1016\/j.bmc.2026.118778_bb0175","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J Comput Chem"},{"issue":"10","key":"10.1016\/j.bmc.2026.118778_bb0180","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jcc.21787","article-title":"MDAnalysis: a toolkit for the analysis of molecular dynamics simulations","volume":"32","author":"Michaud-Agrawal","year":"2011","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2026.118778_bb0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"1","key":"10.1016\/j.bmc.2026.118778_bb0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13321-021-00548-6","article-title":"ProLIF: a library to encode molecular interactions as fingerprints","volume":"13","author":"Bouysset","year":"2021","journal-title":"J Cheminform"},{"issue":"10","key":"10.1016\/j.bmc.2026.118778_bb0195","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J Chem Theory Comput"},{"issue":"1","key":"10.1016\/j.bmc.2026.118778_bb0200","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1021\/ct600085e","article-title":"Generalized born model with a simple, robust molecular volume correction","volume":"3","author":"Mongan","year":"2007","journal-title":"J Chem Theory Comput"},{"issue":"1","key":"10.1016\/j.bmc.2026.118778_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118778_bb0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"64","author":"Lipinski","year":"2012","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T08:37:14Z","timestamp":1788597434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":42,"alternative-id":["S0968089626002348"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118778","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel hydrazone-linked pyridin-1-ium salts as multi-targeted agents for Alzheimer's disease: design, synthesis, in vitro and in silico studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118778"}}